Recombinant murine interleukin 4 protein therapy for psoriasis in a transgenic VEGF mouse model.
Ren, Xiaoxiao
Recombinant murine interleukin 4 protein therapy for psoriasis in a transgenic VEGF mouse model. [electronic resource] - Dermatology (Basel, Switzerland) 2009 - 232-8 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
1421-9832
10.1159/000235974 doi
Animals
Disease Models, Animal
Ear--pathology
Gene Expression
Immunohistochemistry
Injections
Injections, Subcutaneous
Interferon-gamma--biosynthesis
Interleukin-4--administration & dosage
Mice
Mice, Transgenic
Neovascularization, Pathologic--pathology
Psoriasis--drug therapy
RNA, Messenger--genetics
Recombinant Proteins--administration & dosage
Treatment Outcome
Vascular Endothelial Growth Factor A--metabolism
Recombinant murine interleukin 4 protein therapy for psoriasis in a transgenic VEGF mouse model. [electronic resource] - Dermatology (Basel, Switzerland) 2009 - 232-8 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
1421-9832
10.1159/000235974 doi
Animals
Disease Models, Animal
Ear--pathology
Gene Expression
Immunohistochemistry
Injections
Injections, Subcutaneous
Interferon-gamma--biosynthesis
Interleukin-4--administration & dosage
Mice
Mice, Transgenic
Neovascularization, Pathologic--pathology
Psoriasis--drug therapy
RNA, Messenger--genetics
Recombinant Proteins--administration & dosage
Treatment Outcome
Vascular Endothelial Growth Factor A--metabolism